Skip To Content
Calvin Leung

Calvin Leung

Associate, Corporate


Contact Information

cleung@osler.com

tel: 514.904.5805

Office

Montréal

Areas of Expertise
Bar Admission

Québec, 2015

Education
  • Queen's University, J.D.
  • McGill University, B.Sc.
  • ​Université de Montréal, LL.B.

  •  
Language(s)
French, English

Calvin is an associate in the Montréal office and a member of the Corporate Group. He practises in commercial law, with an emphasis on mergers and acquisitions, venture capital, private equity and technology. He advises domestic and international clients on a wide range of issues, including acquisitions and sales of private businesses, capital investments, outsourcing arrangements, strategic alliances, technology, distribution, development and licensing, information technology and e-commerce issues.  Before joining the firm, Calvin practiced in another Canadian law firm.

  • Caisse de dépôt et placement du Québec

    Caisse de dépôt et placement du Québec in its $200 million investment in Plusgrade

  • Alithya Group Inc.

    Alithya Group Inc., in its going public transaction by way of a business combination with Edgewater Technology, Inc. and completion of a $52.8 million concurrent private placement

  • Caprion Biosciences

    Caprion Biosciences in its acquisition of Primity Bio

  • Angiochem Inc.

    Angiochem Inc. in its Series C financing round of $7.5 million

  • Inocucor Technologies Inc.

    Inocucor Technologies Inc. in its acquisition of ATP Nutrition Inc.

  • NorthOne

    NorthOne in its Seed Funding round of $2 million

    • Caisse de dépôt et placement du Québec, in multiple venture capital investments.
    • Cycle Capital and Desjardins-Innovatech, in their participation to a $38.8M Series B financing lead by TPG Alternative and Renewable Technologies (TPG ART) in Inocucor Corporation.
    • Fonds de Solidarité FTQ, in connection with a VC investment in Kaloom Inc. (Montreal/Silicon Valley software venture).
    • BDC Capital Inc., in connection with investments in Budge Studios.
    • Teralys Capital, a fund manager financing private venture capital funds, in connection with their investments in White Star Capital Canada Limited Partnership, Persistence Capital Partners II, L.P., Sofinnova Capital VIII and Versant Venture Capital VI, L.P.
    • Marketel-McCann and its majority shareholders, in the sale to McCann Canada (media/advertising).
    • IQVIA, in connection with its acquisition of Privacy Analytics Incorporated, a leader in technology solutions for de-identifying and anonymizing healthcare information.
    • Bell Media, in the acquisition of Metromedia from Cogeco.
    • Fonds de Solidarité FTQ, Capital régional et coopératif Desjardins and Fondaction CSN, in connection with their joint acquisition of door and window manufacturer Atis Group Inc. from Ohio-based private equity fund Cyprium Partners.
  • Find More